Relationship between sarcopenic obesity-related phenotypes and inflammatory markers in postmenopausal women

Clinical Physiology and Functional Imaging

Volumn 37, Issue 2, 2017, Pages 205-210

  Dutra, Maurílio Tiradentes ^a,b   Avelar, Bruna Pereira ^a   Souza, Vinícius Carolino ^c   Bottaro, Martim ^a   Oliveira, Ricardo Jacó ^a   Nóbrega, Otávio Toledo ^a   Moreno Lima, Ricardo ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b Technical School of Health of Planaltina   (Brazil)

^c UNIVERSIDADE CATÓLICA DE BRASÍLIA   (Brazil)

Author keywords

cytokines; fat; inflammation; sarcopenia; strength

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR; AUTACOID; BIOLOGICAL MARKER; IL6 PROTEIN, HUMAN;

AGED; ARTICLE; BODY COMPOSITION; BODY FAT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT MASS; FEMALE; GRIP STRENGTH; HUMAN; MUSCLE MASS; PATHOGENESIS; PHENOTYPE; POPULATION RESEARCH; POSTMENOPAUSE; SARCOPENIC OBESITY; WAIST CIRCUMFERENCE; BLOOD; HAND STRENGTH; INFLAMMATION; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; SARCOPENIA; SKELETAL MUSCLE;

ABSORPTIOMETRY, PHOTON; ADIPOSITY; AGED; BIOMARKERS; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; HAND STRENGTH; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MIDDLE AGED; MUSCLE, SKELETAL; OBESITY; PHENOTYPE; POSTMENOPAUSE; SARCOPENIA; TUMOR NECROSIS FACTOR-ALPHA; WAIST CIRCUMFERENCE;

EID: 84941703138     PISSN: 14750961     EISSN: 1475097X     Source Type: Journal    
DOI: 10.1111/cpf.12287     Document Type: Article

References (27)

1. Alemán H, Esparza J, Ramirez FA, et al. Longitudinal evidence on the association between interleukin-6 and C-reactive protein with the loss of total appendicular skeletal muscle in free-living older men and women. Age Ageing (2011); 40: 469–475.
2. Barbieri M, Ferrucci L, Ragno E, et al. Chronic inflammation and the effect of IGF-1 on muscle strength and power in older persons. Am J Physiol Endocrinol Metab (2003); 284: E481–E487.
3. Cesari M, Kritchevsky SB, Baumgartner RN, et al. Sarcopenia, obesity, and inflammation: results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study. Am J Clin Nutr (2005); 82: 428–434.
4. Harkonen R, Piirtomaa M, Alaranta H. Grip strength and hand position of the dynamometer in 204 Finnish adults. J Hand Surg Br (1993); 18B: 129–132.
5. Janssen I, Shepard D, Katzmarzyk PT, et al. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc (2004); 52: 80–85.
6. Jarosz PA, Bellar A. Sarcopenic obesity: an emerging cause of frailty in older adults. Geriatr Nurs (2009); 30: 64–70.
7. Langkilde A, Andersen O, Henriksen J, et al. Assessment of in situ adipose tissue inflammation by microdialysis. Clin Physiol Funct Imaging (2015); 35: 110–119.
8. Licastro F, Candore G, Lio D, et al. Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun Ageing (2005); 2: 8.
9. Lima RM, Bezerra LMA, Rabelo HT, et al. Fat-free mass, strength, and sarcopenia are related to bone mineral density in older women. J Clin Densitom (2009); 12: 35–41.
10. Matsudo S, Araújo T, Matsudo V, et al. Questinário internacional de atividade física (IPAQ): estudo de validade e reprodutibilidade no Brasil/International physical activity questionnaire (IPAQ): study of validity and reability in Brazil. Rev Bras Ativ Fís Saúde (2001); 6: 5–18.
11. Narici MV, Maffulli N. Sarcopenia: characteristics, mechanisms and functional significance. Br Med Bull (2010); 95: 139–159.
12. Newman AB, Kupelian V, Visser M, et al. Sarcopenia. Alternative definitions and associations with lower extremity function. J Am Geriatr Soc (2003); 51: 1602–1609.
13. Oliveira DMG, Narciso FMS, Santos MLAS, et al. Muscle strength but not functional capacity is associated with plasma interleukin-6 levels of community-dwelling elderly women. Braz J Med Biol Res (2008); 41: 1148–1153.
14. Oliveira RJ, Bottaro M, Mota AM, et al. Association between sarcopenia-related phenotypes with aerobic capacity indexes of older women. J Sci Med Sport (2009); 8: 337–343.
15. Oliveira RJ, Bottaro M, Júnior JT, et al. Identification of sarcopenic obesity in postmenopausal women: a cutoff proposal. Braz J Med Biol Res (2011); 44: 1171–1176.
16. Pereira GB, Tibana RA, Navalta J, et al. Acute effects of resistance training on cytokines and osteoprotegerin in women with metabolic syndrome. Clin Physiol Funct Imaging (2013); 33: 122–130.
17. Rosa TEC, Benício MHD, Latorre MRDO, et al. Determinant factors of functional status among the elderly. Rev Saúde Pública (2003); 37: 40–48.
18. Schaap LA, Pluijm SMF, Deeg DJH, et al. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med (2006); 119: 526.e9–526.e17.
19. Schrager MA, Metter EJ, Simonsick E, et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol (2007); 102: 919–925.
20. Sipila S. Body composition and muscle performance during menopause and hormone replacement therapy. J Endocrinol Invest (2003); 26: 893–901.
21. Stephen WC, Janssen I. Sarcopenic-obesity and cardiovascular disease risk in the elderly. J Nutr Health Aging (2009); 13: 460–466.
22. Van Hall G, Steensberg A, Fischer C, et al. Interleukin-6 markedly decreases skeletal muscle protein turnover and increases nonmuscle amino acid utilization in healthy individuals. J Clin Endocrinol Metab (2008); 93: 2851–2858.
23. Visser M, Pahor P, Taaffe D, et al. Relationship of interleukin-6 and tumour necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci (2002); 57: M326–M332.
24. Vitale C, Gebara O, Mercuro G, et al. Value of C-reactive protein levels and IL-6 in predicting events levels in women at increased cardiovascular risk. Maturitas (2005); 50: 239–246.
25. Walrand S, Guillet C, Salles J, et al. Physiopathological mechanism of sarcopenia. Clin Geriatr Med (2011); 27: 365–385.
26. Waters DL, Baumgartner RN. Sarcopenia and obesity. Clin Geriatr Med (2011); 27: 401–421.
27. Yaffe K, Kanaya A, Lindquist K, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA (2004); 292: 2237–2242.